Background and study aim: Heart diseases are among the most common causes of death worldwide. A large proportion of deaths are caused by heart attacks (myocardial infarction), where blood flow to the heart is reduced resulting in damage to the heart muscle. If the arteries supplying blood to the heart start to become blocked, Coronary Artery Bypass Grafting (CABG) surgery is a treatment to replace the blocked sections of artery can reduce angina (chest pain). However, CABG surgery has complications, including an increased risk of heart attack. Vitamin D deficiency is thought to be linked to poorer recovery from heart attack and CABG surgery. This study aims to investigate if vitamin D supplementation can reduce injury to the heart following CABG surgery. Who can participate? Adults with vitamin D deficiency undergoing CABG What does the study involve? Participants are randomly allocated to one of two groups. Those in the first group receive vitamin D at 3 doses per day for 3 days before surgery. The second group will receive a dummy pill (placebo). Both groups will have standard CABG surgery. What are the possible benefits and risks of participating? Those in the vitamin D group might benefit from its effects. Vitamin D has few side effects, especially when taken for only a few days. Where is the study run from? Shahid Modarres Hospital (Iran) When is the study starting and how long is it expected to run for? September 2017 to January 2019 Who is funding the study? Deputy of Research of Shahid Beheshti School of Medicine Who is the main contact? Dr Erfan Tasdighi erfan.tasdighi@gmail.com
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Caspase 2 Enzyme Level
Timeframe: during the surgery, an average of 3 hours
Caspase 3 Enzyme Level, an Average of 3 Hours
Timeframe: during the surgery, an average of 3 hours
Caspase 7 Enzyme Level
Timeframe: during the surgery, an average of 3 hours
Interlukin-10 (IL-10) Serum Level
Timeframe: Right before the intervention(3 days before surgery)
Interleukin-10 (IL-10) Serum Level
Timeframe: procedure (before anesthesia induction)
Interleukin--10 (IL-10) Serum Level
Timeframe: at the end of surgery after protamine reversal
Interleukin (IL-10) Serum Level
Timeframe: the first postoperative day
Insulin Growth Factor
Timeframe: Right before the intervention(3 days before surgery)
Insulin Growth Factor
Timeframe: procedure (before anesthesia induction)
Insulin Growth Factor
Timeframe: at the end of surgery after protamine reversal
Insulin Growth Factor
Timeframe: the first postoperative day